The concentration, purity, and sterility of the peptide you administer directly affects whether the results are consistent and safe
The results reported that AngIV had a very short half life of less than 2 minutes, however, each of the N-terminal modified compounds, such as Dihexa, exhibited elongated half-lives in comparison to the parent compound
preparation of the manuscript
Evidence of such side effects was evident in our latest analysis of brands to watch in 2024, where both Ducolax and Miralax made the list of fastest-growing brands among GLP-1 users in 2023
Importantly, many of these challenges are now tractable using contemporary approaches to peptide engineering, receptor biology, and translational trial design